UnitedHealth Group Faces Unprecedented Crisis Amid DOJ Probe

UnitedHealth Group's shares plummeted following news of a DOJ investigation into potential Medicare fraud, compounding existing challenges including leadership changes and government scrutiny. The health insurer has already experienced significant stock declines, exacerbated by concerns over its business practices.

UnitedHealth Group shares suffered a significant 16% drop, plunging to a five-year low on Thursday, following a Wall Street Journal report about a Department of Justice investigation into potential Medicare fraud.

The health insurer faces mounting issues, including multiple government inquiries, leadership changes, and financial outlook uncertainties, with minimal details emerging about the investigation, heightening investor concerns.

CEO Andrew Witty's abrupt departure, combined with the company's forecast withdrawal, preceded this crisis, leading UnitedHealth shares to a historic low, causing ripple effects throughout the health insurance industry.